» Articles » PMID: 19181875

The Role of the Ubiquitin Proteasome System in Ischemia and Ischemic Tolerance

Overview
Journal Neuroscientist
Publisher Sage Publications
Specialty Neurology
Date 2009 Feb 3
PMID 19181875
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Ubiquitin modification targets a protein for rapid degradation by the proteasome. However, polyubiquitination of proteins can result in multiple functions depending on the topology of the ubiquitin chain. Therefore, ubiquitin signaling offers a more complex and versatile biology compared with many other posttranslational modifications. One area of potential for the application of this knowledge is the field of ischemia-induced brain damage, as occurs following a stroke. The ubiquitin proteasome system may exert a dual role on neuronal outcome following ischemia. Harmful ischemia results in an overload of the ubiquitin proteasome system, and blocking the proteasome reduces brain infarction following ischemia. However, the rapid and selective degradation of proteins following brief ischemia results in endogenous protection against ischemia. Therefore, further understanding of the molecular signaling mechanisms that regulate the ubiquitin proteasome system may reveal novel therapeutic targets to reduce brain damage when ischemia is predicted or reduce the activation of the cell death mechanisms and the inflammatory response following stroke. The aim of this review is to discuss some of the recent advances in the understanding of protein ubiquitination and its implications for novel stroke therapies.

Citing Articles

Mechanistic exploration of ubiquitination-mediated pathways in cerebral ischemic injury.

Khanra S, Singh S, Singh T Mol Biol Rep. 2024; 52(1):22.

PMID: 39607439 DOI: 10.1007/s11033-024-10123-5.


Potential Biomarkers of Acute Ischemic Stroke Etiology Revealed by Mass Spectrometry-Based Proteomic Characterization of Formalin-Fixed Paraffin-Embedded Blood Clots.

Rossi R, Mereuta O, Barbachan E Silva M, Gil S, Douglas A, Pandit A Front Neurol. 2022; 13:854846.

PMID: 35518205 PMC: 9062453. DOI: 10.3389/fneur.2022.854846.


Exploration on the Mechanism of Ubiquitin Proteasome System in Cerebral Stroke.

Li Y, Wang Y, Zou W Front Aging Neurosci. 2022; 14:814463.

PMID: 35462700 PMC: 9022456. DOI: 10.3389/fnagi.2022.814463.


Inhibition of the immunoproteasome LMP2 ameliorates ischemia/hypoxia-induced blood-brain barrier injury through the Wnt/β-catenin signalling pathway.

Chen X, Wan S, Yao N, Lin Z, Mao Y, Yu X Mil Med Res. 2021; 8(1):62.

PMID: 34857032 PMC: 8641178. DOI: 10.1186/s40779-021-00356-x.


A Screen of Autophagy Compounds Implicates the Proteasome in Mammalian Aminoglycoside-Induced Hair Cell Damage.

Draf C, Wyrick T, Chavez E, Pak K, Kurabi A, Leichtle A Front Cell Dev Biol. 2021; 9:762751.

PMID: 34765606 PMC: 8576371. DOI: 10.3389/fcell.2021.762751.


References
1.
Liu C, Chen S, Kamme F, Hu B . Ischemic preconditioning prevents protein aggregation after transient cerebral ischemia. Neuroscience. 2005; 134(1):69-80. PMC: 3518067. DOI: 10.1016/j.neuroscience.2005.03.036. View

2.
Kerscher O, Felberbaum R, Hochstrasser M . Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu Rev Cell Dev Biol. 2006; 22:159-80. DOI: 10.1146/annurev.cellbio.22.010605.093503. View

3.
Bossenmeyer-Pourie C, Daval J . Prevention from hypoxia-induced apoptosis by pre-conditioning: a mechanistic approach in cultured neurons from fetal rat forebrain. Brain Res Mol Brain Res. 1998; 58(1-2):237-9. DOI: 10.1016/s0169-328x(98)00123-5. View

4.
Dirnagl U, Iadecola C, Moskowitz M . Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999; 22(9):391-7. DOI: 10.1016/s0166-2236(99)01401-0. View

5.
Oddo S . The ubiquitin-proteasome system in Alzheimer's disease. J Cell Mol Med. 2008; 12(2):363-73. PMC: 3822529. DOI: 10.1111/j.1582-4934.2008.00276.x. View